|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Adaptimmune Therapeutics PLC (ADAP)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-01-14 Sale |
2019-01-16 9:31 pm |
Adaptimmune Therapeutics PLC | ADAP | Binder-Scholl Gwendolyn Knowlton CTO |
1,514 | $5.369 | $8,129 | 2,487 (Direct) |
View |
| 2019-01-14 Sale |
2019-01-16 9:31 pm |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR COO |
2,271 | $5.369 | $12,194 | 3,731 (Direct) |
View |
| 2019-01-14 Sale |
2019-01-16 9:31 pm |
Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President |
3,028 | $5.369 | $16,259 | 4,974 (Direct) |
View |
| 2019-01-14 Sale |
2019-01-16 9:30 pm |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO |
3,084 | $5.369 | $16,559 | 3,318 (Direct) |
View |
| 2018-12-17 Purchase |
2018-12-19 8:04 pm |
Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director |
47,280 | $0.84 | $39,715 | 70,584 (Direct Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:49 pm |
Adaptimmune Therapeutics PLC | ADAP | Viswanathan Ravi 10% Owner |
15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:49 pm |
Adaptimmune Therapeutics PLC | ADAP | Sonsini Peter W. 10% Owner |
15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:49 pm |
Adaptimmune Therapeutics PLC | ADAP | SANDELL SCOTT D 10% Owner |
15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:48 pm |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director, 10% Owner |
15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:48 pm |
Adaptimmune Therapeutics PLC | ADAP | KERINS PATRICK J 10% Owner |
3,000,000 | $1.667 | $5,000,100 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:47 pm |
Adaptimmune Therapeutics PLC | ADAP | Florence Anthony A. Jr. 10% Owner |
15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:47 pm |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
12,000,000 | $1.667 | $20,000,400 | 12,000,000 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:46 pm |
Adaptimmune Therapeutics PLC | ADAP | BASKETT FOREST 10% Owner |
15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:46 pm |
Adaptimmune Therapeutics PLC | ADAP | BARRIS PETER J 10% Owner |
15,000,000 | $1.667 | $25,000,500 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:45 pm |
Adaptimmune Therapeutics PLC | ADAP | BARRETT M JAMES 10% Owner |
3,000,000 | $1.667 | $5,000,100 | 82,978,672 (Indirect) |
View |
| 2018-09-07 Purchase |
2018-09-10 4:45 pm |
Adaptimmune Therapeutics PLC | ADAP | New Enterprise Associates 14 L.P. NEA Partners 14 L.P. NEA 14 GP LTD 10% Owner |
3,000,000 | $1.667 | $5,000,100 | 82,978,672 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-07-02 Option Award |
2019-07-03 5:41 pm |
2020-07-20 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director, 10% Owner |
350,947 | $0.61 | 350,947 (Direct) |
View |
| 2019-07-02 Option Award |
2019-07-03 5:40 pm |
2020-07-02 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
234,407 | $0.61 | 234,407 (Direct) |
View |
| 2019-07-02 Option Award |
2019-07-03 5:01 pm |
2020-07-02 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director |
124,000 | $0.61 | 124,000 (Direct) |
View |
| 2019-07-02 Option Award |
2019-07-03 5:00 pm |
2020-07-02 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Sigal Charles Elliott Director |
234,407 | $0.61 | 234,407 (Direct) |
View |
| 2019-07-02 Option Award |
2019-07-03 5:00 pm |
2020-07-02 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Furey John Director |
240,541 | $0.61 | 240,541 (Direct) |
View |
| 2019-07-02 Option Award |
2019-07-03 5:00 pm |
2020-07-02 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Kerr Giles Francis Bertram Director |
124,000 | $0.61 | 124,000 (Direct) |
View |
| 2019-07-02 Option Award |
2019-07-03 5:00 pm |
2020-07-02 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director |
124,000 | $0.61 | 124,000 (Direct) |
View |
| 2019-07-02 Option Award |
2019-07-03 5:00 pm |
2020-07-02 2029-07-02 |
Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director |
271,209 | $0.61 | 271,209 (Direct) |
View |
| 2019-06-27 Option Award |
2019-06-27 8:00 pm |
N/A 2029-06-27 |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO |
628,872 | $0.68 | 628,872 (Direct) |
View |
| 2019-06-27 Option Award |
2019-06-27 8:00 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO |
140,448 | $0.0013 | 628,872 (Direct) |
View |
| 2019-05-16 Exercise |
2019-05-17 6:00 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Noble James CEO |
1,773,100 | $0.143 | 12,945,700 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:02 pm |
N/A 2029-01-04 |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR COO |
1,006,224 | $0.89 | 1,006,224 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:02 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR COO |
224,724 | $0.0013 | 1,006,224 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:01 pm |
N/A 2029-01-04 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
1,006,224 | $0.89 | 1,006,224 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:01 pm |
N/A 2029-01-04 |
Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business Officer |
224,724 | $0.0013 | 1,006,224 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:01 pm |
N/A 2029-01-04 |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO |
1,257,744 | $0.89 | 1,257,744 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:01 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian CFO |
280,896 | $0.0013 | 1,257,744 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:01 pm |
N/A 2029-01-04 |
Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President |
1,006,224 | $0.89 | 1,006,224 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:01 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President |
224,724 | $0.0013 | 1,006,224 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:00 pm |
N/A 2029-01-04 |
Adaptimmune Therapeutics PLC | ADAP | Noble James CEO |
2,515,536 | $0.89 | 2,515,536 (Direct) |
View |
| 2019-01-04 Option Award |
2019-01-08 9:00 pm |
N/A 2029-01-04 |
Adaptimmune Therapeutics PLC | ADAP | Noble James CEO |
561,792 | $0.0013 | 2,515,536 (Direct) |
View |
| 2018-10-01 Sale |
2018-10-02 7:58 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Binder-Scholl Gwendolyn Knowlton CTO |
25,000 | $13.79 | 0 (Direct) |
View |
| 2018-08-29 Sale |
2018-08-31 8:02 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Binder-Scholl Gwendolyn Knowlton CTO |
25,000 | $10.25 | 0 (Direct) |
View |
| 2018-08-06 Option Award |
2018-08-07 5:14 pm |
N/A N/A |
Adaptimmune Therapeutics PLC | ADAP | Amado Rafael President |
678,720 | $0.0013 | 678,720 (Direct) |
View |
| 2018-06-22 Option Award |
2018-06-26 5:07 pm |
2019-06-22 2028-06-22 |
Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director, 10% Owner |
187,330 | $2.18 | 187,330 (Direct) |
View |
| 2018-06-22 Option Award |
2018-06-26 5:05 pm |
2019-06-22 2028-06-22 |
Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director |
154,809 | $2.18 | 154,809 (Direct) |
View |
| 2018-06-22 Option Award |
2018-06-26 5:01 pm |
2019-06-22 2028-06-22 |
Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director |
124,000 | $2.18 | 124,000 (Direct) |
View |
| 2018-06-22 Option Award |
2018-06-26 5:01 pm |
2019-06-22 2028-06-22 |
Adaptimmune Therapeutics PLC | ADAP | Zaks Tal Zvi Director |
124,000 | $2.18 | 124,000 (Direct) |
View |
| 2018-06-22 Option Award |
2018-06-26 5:00 pm |
2019-06-22 2028-06-22 |
Adaptimmune Therapeutics PLC | ADAP | Kerr Giles Francis Bertram Director |
124,000 | $2.18 | 124,000 (Direct) |
View |
| 2018-06-22 Option Award |
2018-06-26 5:00 pm |
2019-06-22 2028-06-22 |
Adaptimmune Therapeutics PLC | ADAP | Duncan Barbara Gayle Director |
158,233 | $2.18 | 158,233 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Mon, 22 Jul 2019 20:12:54 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |